MDGL vs PAYC · rev $180.1M vs P/E 33, rev $1.88B
Madrigal Pharmaceuticals Inc (MDGL) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
MDGL currently screens at market cap $11.56B. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the MDGL and PAYC stock pages for the full models.
Not investment advice.